Glutathione Deficiency as a Novel Risk Factor for Alzheimer’s Disease: Implications for GlyNAC Supplementation
2024

Glutathione Deficiency and Alzheimer's Disease

Sample size: 32 publication

Author Information

Author(s): Taffet George, Kumar Premranjan, Osahon Ob, Onyechi Chimaoge, Minard Charles, Masdeu Joseph, Sekhar Rajagopal

Primary Institution: Baylor College of Medicine

Hypothesis

Patients with Alzheimer's disease with mild cognitive impairment will have greater glutathione deficiency than older adults.

Conclusion

Alzheimer's disease with mild cognitive impairment is associated with severe glutathione deficiency.

Supporting Evidence

  • Cognitive impairment in Alzheimer's disease is linked to oxidative stress and glutathione deficiency.
  • GlyNAC supplementation improved glutathione levels in aged mice.
  • Young adults had the highest levels of total glutathione compared to older adults and Alzheimer's patients.

Takeaway

People with Alzheimer's disease often have low levels of an important antioxidant called glutathione, and a supplement might help improve this.

Methodology

Compared intracellular red-blood cell glutathione concentrations in young adults, older adults without cognitive impairment, and patients with Alzheimer's disease and mild cognitive impairment.

Participant Demographics

32 patients with Alzheimer's disease and mild cognitive impairment, 32 older adults, and 19 young adults.

Digital Object Identifier (DOI)

10.1093/geroni/igae098.0810

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication